Fintel reports that on January 3, 2025, Guggenheim upgraded their outlook for Surrozen (NasdaqCM:SRZN) from Neutral to Buy.

Yang Li, the Exec. Vice President of $SRZN ($SRZN), sold 843 shares of the company on 01-03-2025. We received data on the trade from a recent SEC filing. This was a ...

Charles O Williams, the CFO and COO of $SRZN ($SRZN), sold 1,181 shares of the company on 01-03-2025. We received data on the trade from a recent SEC filing. This was ...

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted ...

Shares of SRZN opened at $14.25 on Friday. Surrozen has a fifty-two week low of $6.00 and a fifty-two week high of $16.19. The firm has a 50-day simple moving average of $10.78 and a 200-day ...

As previously reported, Guggenheim upgraded Surrozen (SRZN) to Buy from Neutral with a $45 price target Recent Phase 1b data for SZN-043, the ...

Guggenheim analyst Yatin Suneja upgraded Surrozen (SRZN) to Buy from Neutral with a $45 price target Don't Miss Our New Year's Offers:Discover ...

Raymond James downgraded RingCentral (RNG) to Outperform from Strong Buy with a price target of $45, down from $50. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt ...